$429.48
-0.17-0.04%
Últ. Act.: Nov 11, 5:31 PM
Elevance Health rose 31.1% from $327.63 to $429.48, ahead of the S&P 500's +11.2%. Its worst day was Jan 27 (−14.3%), and its low came Mar 9 at $279.02.
Nov 12, 2025 – Nov 11, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Elevance Health shares rose 5.6%, while the S&P 500 rose 0.2%.
+5.6% · S&P 500 +0.2%
EPS of $3.33 beat the $3.10 estimate on $49.3B revenue (est. $49.5B); FY EPS guidance of $25.50 against the $26.89 consensus.
Story events cover the past 12 months · Times ET
+5.9% · S&P 500 0.0%
Elevance Health closed at its lowest level of the year, 14.8% below where the year started.
−3.7% · S&P 500 +0.9%
EPS of $12.58 beat the $10.74 estimate on $49.5B revenue (est. $48.0B); FY EPS guidance of $26.75 against the $25.81 consensus.
0.0% · S&P 500 +1.0%
Elevance Health shares rose 7.6%, while the S&P 500 fell 0.1%.
+7.6%, the year's best day · S&P 500 −0.1%
EPS of $7.45 beat the $6.20 estimate on $49.8B revenue (est. $48.6B); FY EPS guidance of $27.00 against the $26.89 consensus.
−8.5% · S&P 500 +0.4%
EPS of $6.99 beat the $4.69 estimate on $50.4B revenue (est. $49.0B); FY EPS guidance of $29.00 against the $27.24 consensus.
−1.4% · S&P 500 +0.5%
Where it ended: a close of $429.48 on Nov 11, 2026. Up next: Q4 2026 earnings on Jan 27, 2027 (EPS est. $2.10, revenue est. $49.0B).
As of the Nov 11, 2026 close
Replay the year: the line draws itself and stops at each of the 7 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for ELV and SPY from Benzinga historical bars. Not investment advice.